Suppr超能文献

肱骨近端骨折患者的阿片类药物使用特点。

The characteristics of opioid use in patients with proximal humerus fractures.

机构信息

Department of Orthopaedic Surgery, Duke University Medical Center, 311 Trent Dr, Durham, NC, USA.

出版信息

Eur J Orthop Surg Traumatol. 2023 Aug;33(6):2405-2409. doi: 10.1007/s00590-022-03443-4. Epub 2022 Dec 2.

Abstract

BACKGROUND

Orthopaedic surgeons prescribe more opioid narcotics than any other surgical specialty. Proximal humerus fractures (PHF) often occur in the high-risk elderly population. The opioid epidemic has led to public policy aimed at reductions in opioid prescription. This study aimed to evaluate the impact that new legislation has had on opioid prescription patterns in patients who sustained proximal humerus fractures.

METHODS

A retrospective review of all patients who sustained PHF at a single academic institution from 1/1/2015-12/31/2019 was performed. A total of 762 proximal humerus fractures were identified and final analysis included 383 patients. Collected data included basic demographics and opioid prescriptions obtained through review of the electronic medical record. The North Carolina Strengthen Opioid Misuse Prevention act legislation that went into effect on July 1, 2017.

RESULTS

There was no difference in the number of pre- or postoperative opioid prescriptions provided with the new legislation. Our data showed a significant reduction in MeQs prescribed preoperatively pre-STOP act (188.1 MeQs) and post-STOP act (99.4 MeQs). There was also a significant difference in the amount of postoperative narcotics prescribed in the pre-STOP (972.6 MeQs) and post-STOP act (508.6 MeQs) groups (p < 0.01).

CONCLUSIONS

With the enactment of the STOP act in North Carolina, we have seen a significant reduction in the amount of narcotic prescribed after sustaining a proximal humerus fracture preoperatively and postoperatively. This data demonstrates the impact that implementation of state-wide regulatory changes in opioid prescribing policy has had for a common orthopedic condition.

摘要

背景

矫形外科医生开具的阿片类药物比任何其他外科专业都多。肱骨近端骨折(PHF)常发生在高危老年人群中。阿片类药物流行导致了旨在减少阿片类药物处方的公共政策。本研究旨在评估新立法对肱骨近端骨折患者阿片类药物处方模式的影响。

方法

对一家学术机构 2015 年 1 月 1 日至 2019 年 12 月 31 日期间所有肱骨近端骨折患者进行回顾性分析。共确定 762 例肱骨近端骨折,最终分析纳入 383 例患者。收集的数据包括基本人口统计学资料和通过电子病历审查获得的阿片类药物处方。北卡罗来纳州加强阿片类药物滥用预防法案于 2017 年 7 月 1 日生效。

结果

新法颁布前后,阿片类药物的术前和术后处方数量没有差异。我们的数据显示,在停止法案之前,术前规定的 MeQs 显著减少(188.1 MeQs),停止法案之后(99.4 MeQs)。术前(972.6 MeQs)和术后(508.6 MeQs)组之间术后开的阿片类药物数量也有显著差异(p<0.01)。

结论

随着北卡罗来纳州停止法案的颁布,我们发现肱骨近端骨折患者术前和术后阿片类药物的用量显著减少。这一数据表明,在全州范围内实施阿片类药物处方政策的监管变化对常见的骨科疾病产生了影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验